| Dr David G Blancho, DPM | |
|
444 Four States Dr, Ste 1, Galena, KS 66739-4324 | |
| (620) 783-4441 | |
| (620) 783-4090 |
| Full Name | Dr David G Blancho |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 11 Years |
| Location | 444 Four States Dr, Galena, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366753055 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | SC006185 (Pennsylvania) | Primary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 2013028529 (Missouri) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Specialty Hospital Southeast Kansas | Galena, KS | Hospital |
| Mercy Hospital Carthage | Carthage, MO | Hospital |
| Mercy Hospital Joplin | Joplin, MO | Hospital |
| Via Christi Hospital Pittsburg Inc | Pittsburg, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Joplin Llc | 0547300196 | 247 |
| Mercy Clinic Joplin Llc | 0547300196 | 247 |
News Archive
A team of immunologists from RUDN University suggested a new tool to control inflammation levels in asthma patients with accompanying diseases.
Higher blood levels of the compound urate, a salt derived from uric acid that is associated with gout, may be associated with a slower progression of Parkinson's disease, according to an article posted online today that will appear in the June 2008 print issue of Archives of Neurology.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
In the wake of cannabis legalization, a team of scientists at the Research Institute of the McGill University Health Center and McGill University have delivered encouraging news for chronic pain sufferers by pinpointing the effective dose of marijuana plant extract cannabidiol for safe pain relief without the typical "high" or euphoria produced by the THC.
› Verified 3 days ago
| Provider Name | Mercy Clinic Joplin Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215264817 PECOS PAC ID: 0547300196 Enrollment ID: O20091218000092 |
News Archive
A team of immunologists from RUDN University suggested a new tool to control inflammation levels in asthma patients with accompanying diseases.
Higher blood levels of the compound urate, a salt derived from uric acid that is associated with gout, may be associated with a slower progression of Parkinson's disease, according to an article posted online today that will appear in the June 2008 print issue of Archives of Neurology.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
In the wake of cannabis legalization, a team of scientists at the Research Institute of the McGill University Health Center and McGill University have delivered encouraging news for chronic pain sufferers by pinpointing the effective dose of marijuana plant extract cannabidiol for safe pain relief without the typical "high" or euphoria produced by the THC.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David G Blancho, DPM Po Box 2546, Joplin, MO 64803-2546 Ph: (620) 783-4441 | Dr David G Blancho, DPM 444 Four States Dr, Ste 1, Galena, KS 66739-4324 Ph: (620) 783-4441 |
News Archive
A team of immunologists from RUDN University suggested a new tool to control inflammation levels in asthma patients with accompanying diseases.
Higher blood levels of the compound urate, a salt derived from uric acid that is associated with gout, may be associated with a slower progression of Parkinson's disease, according to an article posted online today that will appear in the June 2008 print issue of Archives of Neurology.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
In the wake of cannabis legalization, a team of scientists at the Research Institute of the McGill University Health Center and McGill University have delivered encouraging news for chronic pain sufferers by pinpointing the effective dose of marijuana plant extract cannabidiol for safe pain relief without the typical "high" or euphoria produced by the THC.
› Verified 3 days ago